20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Schistosomiasis control: experiences and lessons from China

      discussion
      a , b , c
      Lancet (London, England)
      Elsevier Ltd.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Schistosomiasis is a chronic and debilitating disease that also exacerbates poverty. The disease is endemic in the tropics and subtropics, including China.1, 2 Worldwide, almost 800 million individuals are at risk. About 200 million people are infected, over half of whom have various degrees of morbidity, 2 which leads to a disease burden that might be as high as 4·5 million disability-adjusted life-years. This estimate of burden, however, might considerably underestimate the true burden of schistosomiasis. 3 Schistosomiasis is often neglected, because it mainly affects poor rural communities in developing countries. 4 In China, however, the public-health and socioeconomic importance of schistosomiasis was recognised already in the 1950s, as documented in Mao Zedong's poem Farewell, God of Plague. 5 Political will, sustained financial and technical support, and an integrated approach readily adapted to different eco-epidemiological settings and fine-tuned over time have substantially reduced the burden of schistosomiasis. For example, although there were more than 10 million individuals infected with Schistosoma japonicum in 12 provinces of southern China in the mid-1950s, this number was reduced to less than 1 million half a century later. 6 In parallel, transmission was interrupted in five provinces. However, further progress has been hampered by many factors, such as climate change, profound demographic and ecological transformations, market-based reforms of the health sector, and the termination of the World Bank loan project on schistosomiasis control in 2001.5, 7, 8 Re-emergence of schistosomiasis, at least in hilly environments of Sichuan province, is a growing concern. 9 At present, most schistosomiasis cases are concentrated in lake and marshland regions. 6 Since 2004, after the outbreak of severe acute respiratory syndrome 10 and fuelled by the potential re-emergence of schistosomiasis in China, the disease has moved up as one of the top public-health priorities, and is now in the same league as HIV/AIDS, tuberculosis, and hepatitis B. Several features in the life cycle of S japonicum govern its epidemiology and need to be taken into account for disease control. First, Oncomelania spp, the intermediate host snail of S japonicum, is amphibious. These snails can, therefore, proliferate in an array of habitats, such as networks of water in lakes and marshlands and in different kinds of microhabitats in hilly and mountainous environments. Second, more than 40 species of mammals can act as reservoir hosts. Domestic water buffaloes in marshland regions are of particular relevance: these buffaloes can contribute up to 90% of the transmission of S japonicum. 5 The Chinese authorities noted some of these issues more than 50 years ago, which guided the initial design of the national control programme. With the ultimate aim to eliminate schistosomiasis, many approaches have been used, and the overall strategy has been adapted as new approaches and evidence emerged in response to the changing epidemiology of schistosomiasis.5, 8 Early efforts focused on the control of the intermediate host snails and it was thought that schistosomiasis could be eliminated by chemical molluscicides and environmental management that targeted entire snail habitats. 5 Large-scale community participation was a central feature in environmental management. Although the snail habitats were substantially reduced and the number of human infections steadily declined, the disease remained hard to eliminate. In the 1990s, morbidity control was the backbone of disease control, helped by the administration of praziquantel, which had been introduced for large-scale use in the previous decade, coupled with health education. An important lesson learnt during the 10 years of the World Bank loan project was compliance with chemotherapy, which was dropped as the programme evolved. 11 This finding, coupled with factors such as severe flooding of the Yangtze river in the late 1990s, other ecological transformations, and forced movements of population 6 might explain the resurgence of schistosomiasis after the project was terminated. 5 Indeed, the number of acute cases of human schistosomiasis and the snail-infested areas increased at the start of 2000. So what are the lessons from 50 years of schistosomiasis control in China? The panel gives a summary, which we hope will stimulate the scientific community and national schistosomiasis control-managers elsewhere. In view of the remaining challenges for sustainable control of schistosomiasis in China, mid-term and long-term goals have been developed: ie, reduce prevalence of infection by S japonicum below 5% by 2008 (infection control) and decrease infection below 1% by 2015 (transmission control) in all endemic areas. To achieve these targets,5, 12 the feasibility and cost-effectiveness of a four-pronged approach is being investigated in different settings, with the aim of interrupting environmental contamination of schistosome eggs by human beings and bovines. This strategy consists of: first, improved mechanisation of agriculture, to replace buffaloes with tractors. Second, avoidance of marshland pastures and introduction of fenced cattle-farming, as has already been done for pig-farming. Third, installation of sanitation facilities in houses. Fourth and last, provision of toilets for mobile populations (eg, fishermen). 12 Panel Lessons from 50 years of schistosomiasis control in China Governmental policy • Recognition of the public-health significance of schistosomiasis • Political will and commitment to control schistosomiasis Control strategy • Use of multiple interventions in integrated way • Adapt control interventions for specific eco-epidemiological settings and over time as the challenge of control changes Implementation, monitoring, and surveillance • Rigorous surveillance and monitoring of human and bovine prevalence and snail-infested areas Preliminary data from pilot studies suggest that near-complete elimination of S japonicum contamination is possible if such a multipronged strategy is integrated with other control activities. 12 Importantly, such a strategy will not only be effective against schistosomiasis but also against a range of other helminthic diseases (eg, ascariasis, hookworm disease, and trichuriasis) that are still rampant in China. This strategy needs to be adapted in hilly and mountainous areas, although key challenges include the difficulty of mechanising agriculture in hilly terrains and fencing of cattle. Cost-effectiveness in different settings also needs to be investigated, so that schistosomiasis can eventually be eliminated as a public-health problem in mainland China.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk.

          An estimated 779 million people are at risk of schistosomiasis, of whom 106 million (13.6%) live in irrigation schemes or in close proximity to large dam reservoirs. We identified 58 studies that examined the relation between water resources development projects and schistosomiasis, primarily in African settings. We present a systematic literature review and meta-analysis with the following objectives: (1) to update at-risk populations of schistosomiasis and number of people infected in endemic countries, and (2) to quantify the risk of water resources development and management on schistosomiasis. Using 35 datasets from 24 African studies, our meta-analysis showed pooled random risk ratios of 2.4 and 2.6 for urinary and intestinal schistosomiasis, respectively, among people living adjacent to dam reservoirs. The risk ratio estimate for studies evaluating the effect of irrigation on urinary schistosomiasis was in the range 0.02-7.3 (summary estimate 1.1) and that on intestinal schistosomiasis in the range 0.49-23.0 (summary estimate 4.7). Geographic stratification showed important spatial differences, idiosyncratic to the type of water resources development. We conclude that the development and management of water resources is an important risk factor for schistosomiasis, and hence strategies to mitigate negative effects should become integral parts in the planning, implementation, and operation of future water projects.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Control of neglected tropical diseases.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis.

              Schistosomiasis is one of the world's most prevalent infections, yet its effect on the global burden of disease is controversial. Published disability-adjusted life-year (DALY) estimates suggest that the average effect of schistosome infection is quite small, although this is disputed. To develop an evidenced-based reassessment of schistosomiasis-related disability, we did a systematic review of data on disability-associated outcomes for all forms of schistosomiasis. We did structured searches using EMBASE, PUBMED, and Cochrane electronic databases. Published bibliographies were manually searched, and unpublished studies were obtained by contacting research groups. Reports were reviewed and abstracted independently by two trained readers. All randomised and observational studies of schistosomiasis morbidity were eligible for inclusion. We calculated pooled estimates of reported disability-related effects using weighted odds ratios for categorical outcomes and standardised mean differences for continuous data. 482 published or unpublished reports (March, 1921, to July, 2002) were screened. Of 135 selected for inclusion, 51 provided data for performance-related symptoms, whereas 109 reported observed measures of disability-linked morbidities. Schistosomiasis was significantly associated with anaemia, chronic pain, diarrhoea, exercise intolerance, and undernutrition. By contrast with WHO estimates of 0.5% disability weight assigned to schistosomiasis, 2-15% disability seems evident in different functional domains of a person with schistosomiasis. This raised estimate, if confirmed in formal patient-preference studies, indicates a need to reassess our priorities for treating this silent pandemic of schistosomiasis.
                Bookmark

                Author and article information

                Contributors
                Journal
                Lancet
                Lancet
                Lancet (London, England)
                Elsevier Ltd.
                0140-6736
                1474-547X
                17 October 2008
                22-28 November 2008
                17 October 2008
                : 372
                : 9652
                : 1793-1795
                Affiliations
                [a ]Ministry of Health, Beijing, China
                [b ]Department of Public Health and Epidemiology, Swiss Tropical Institute, Basel, Switzerland
                [c ]National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai 200025, China
                Article
                S0140-6736(08)61358-6
                10.1016/S0140-6736(08)61358-6
                7135384
                18930529
                3baeb782-d577-452e-a190-d073de432004
                Copyright © 2008 Elsevier Ltd. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Article

                Medicine
                Medicine

                Comments

                Comment on this article